Gene expression of insulin-like growth factor-I, its receptor and binding proteins in retina under hypoxic conditions

Metabolism: Clinical and Experimental

Volumn 47, Issue 11, 1998, Pages 1331-1336

  Averbukh, Edward ^a   Weiss, Ofra ^b   Halpert, Michael ^b   Yanko, Ravit ^b   Moshe, Rachel ^b   Nephesh, Iris ^b   Flyvbjerg, Allan ^b   Yanko, Lutza ^b   Raz, Itamar ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; AUTORADIOGRAPHY; CENTRAL RETINA ARTERY OCCLUSION; GENE EXPRESSION; GROWTH HORMONE BLOOD LEVEL; HYPEROXIA; HYPOXIA; NEWBORN; NONHUMAN; OXYGEN CONCENTRATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; RECEPTOR DOWN REGULATION; RETINA NEOVASCULARIZATION;

EID: 0031724556     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(98)90300-6     Document Type: Article

References (45)

1. Grant MB, Marner RN, Fitzgerald C, et al: Insulin-like growth factor I acts as an angiogenic agent in rabbit cornea and retina: Comparative studies with basic fibroblast growth factor. Diabetologia 36:282-291, 1993
2. Gimborne MA, Ramzi SC, Leapman SB, et al: Tumor growth and neovascularization: An experimental model using the rabbit cornea. J Natl Cancer Inst 52:412-419, 1974
3. Poulsen JE: The Houssay phenomenon in man: Recovery from retinopathy in a case of diabetes with Simmonds disease. Diabetes 2:7-12, 1953
4. Luft R, Olivecrona H: Hypophysectomy in man: Further experience in severe diabetes mellitus. BMJ 2:753-756, 1955
5. Kohner EM, Joplin GF, Blach RK, et al: Pituitary ablation in the treatment of diabetic retionopathy: A randomized trial. Trans Ophthalmol Soc UK 92:79-90, 1972
6. Bradley RF, Rees SB. Fager SB: Pituitary ablation in the treatment of diabetic retinopathy. Med Clin North Am 49:1105-1124, 1965
7. Mallet B, Vialettes B, Vague P: Stabilization of florid proliferative diabetic retinopathy by long term treatment with SMS 201-995. Diabetologia 34:A42, 1991 (suppl 2, abstr)
8. Lundbek K, Christensen NJ, Jensen VA, et al: Diabetes, diabetic angiopathy and growth hormone (Hypothesis). Lancet 2:131-133, 1970
9. Merimee TJ, Zapf J, Froesch ER: Insulin-like growth factors: Studies in diabetics with and without retinopathy. N Engl J Med 309:527-530, 1983
10. Dills DG, Moss SE, Klein R, et al: Association of elevated IGF-I levels with increased retinopathy in late-onset diabetes. Diabetes 40:1725-1730, 1991
11. Grant MB, Russell B, Fitzgerald C, et al: Insulin-like growth factor in vitreous: Studies in controls and diabetics with neovascularization. Diabetes 35:416-420, 1986
12. Meyer-Schwickerath R, Pfeiffer A, Blum WF, et al: Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects. J Clin Invest 96:2620-2625, 1993
13. Jones JI, Clemmons DR: Insulin-like growth factors and their binding proteins: Biological actions. Endocr Rev 16:3-34, 1995
14. Waldbillig RJ, Jones BE, Schoen TJ, et al: Vitreal insulin-like growth factor binding proteins (IGFBPs) are increased in human and animal diabetics. Curr Eye Res 13:539-546, 1994
15. Reynaud X, Dorey CK: Extraretinal neovascularization induced by hypoxic episodes in the neonatal rat. Invest Ophthalmol Vis Sci 35:3169-3177, 1994
16. McLeod DS, Crone SN, Lutty GA: Vasoproliferation in the neonatal dog model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci 37:1322-1333, 1996
17. Smith LEH, Kopchick JJ, Chen W, et al: Essential role of growth hormone in ischemia-induced retinal neovascularization. Science 276: 1706-1709, 1997
18. Penn JS, Tolman BL, Lowery LA: Variable oxygen exposure causes preretinal neovascularization in the newborn rat. Invest Ophthalmol Vis Sci 34:576-585, 1993
19. Furlanetto RW, Marino JM: Radioimmunossay of somatomedin C/insulin-like growth factor I. Methods Enzymol 146:216-226, 1987
20. Hossenlopp P, Seurin D, Segovia-Quinson B, et al: Analysis of serum insulin-like growth factor binding proteins using Western blotting: Use of the method for titration of the binding proteins and competitive binding studies. Anal Biochem 154:138-143, 1986
21. Flyvbjerg A, Thorlacius-Ussing O, Naeraa R, et al: Kidney tissue somatomedin C and initial renal growth in diabetic and uninephrectomized rats. Diabetologia 31:310-314, 1988
22. Chomczynski P: A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 15:532-534, 1993
23. Lowe WJ, Schaffner AE, Roberts CJ, et al: Developmental regulation of somatostatin gene expression in the brain is region specific. Mol Endocrinol 1:181-187, 1987
24. Werner H, Woloschak M, Adamo M, et al: Developmental regulation of the rat insulin-like growth factor I receptor gene. Proc Natl Acad Sci USA 86:7451-7455, 1989
25. Lowe WJ, Lasky SR, LeRoith D, et al: Distribution and regulation of rat insulin-like growth factor I messenger ribonucleic acids encoding alternative carboxyterminal E-peptides: Evidence for differential processing and regulation in liver. Mol Endocrinol 2:528-535, 1988
26. Brown AL, Chiariotti L, Orlowski CC, et al: Nucleotide sequence and expression of a cDNA clone encoding a fetal rat binding protein for insulin-like growth factors. J Biol Chem 264:5148-5154, 1989
27. Domene H, Krishnamurthi K, Eshet R, et al: Growth hormone (GH) stimulates insulin-like growth factor-I (IGF-I) and IGF-I binding protein-3, but not GH receptor gene expression in livers of juvenile rats. Endocrinology 133:675-682, 1993
28. Lee WH, Wang GM, Seaman LB, et al: Coordinate IGF-I and IGFBP5 gene expression in perinatal rat brain after hypoxia-ischemia. J Cereb Blood Flow Metab 16:227-236, 1996
29. Pfeiffer A, Schatz H: Diabetic microvascular complications and growth factors. Exp Clin Endocrinol 103:7-14, 1995
30. Guan J, Skinner SJ, Beilharz EJ, et al: The movement of IGF-I into the brain parenchyma after hypoxic-ischaemic injury. Neuroreport 7:632-636, 1996
31. Burren CP, Berka JL, Edmondson SR, et al: Localization of mRNA for insulin-like growth factor-I (IGF-I), IGF-I receptor, and IGF binding proteins in rat eye. Invest Ophthalmol Vis Sci 37:1459-1468, 1996
32. Klempt M, Klempt ND, Gluckman PD: Hypoxia and hypoxia/ ischemia affect the expression of insulin-like growth factor binding protein 2 in the developing rat brain. Brain Res Mol Brain Res 17:347-350, 1993
33. Beilharz EJ, Klempt ND, Klempt M, et al: Differential expression of insulin-like growth factor binding proteins (IGFBP) 4 and 5 mRNA in the rat brain after transient hypoxic-ischemic injury. Brain Res Mol Brain Res 18:209-215, 1993
34. Lee WH, Javedan S, Bondy CA: Coordinate expression of insulin-like growth factor system by neurons and neuroglia during retinal and cerebellar development. J Neurosci 52:549-561, 1992
35. Chen JC, Shao ZM, Sheikh MS, et al: Insulin-like growth factor binding protein enhancement of insulin-like growth factor-I (IGF-I) mediated DNA synthesis and IGF-I binding in human breast carcinoma cell line. J Cell Physiol 158:69-78, 1994
36. Conover CA, Powell DR: Insulin-like growth factor (IGF)-binding protein-3 blocks IGF-I-induced down-regulation and cell desensitization in cultured bovine fibroblasts. Endocrinology 129:710-716, 1991
37. Guler HP, Zapf J, Schmid C, et al: Insulin-like growth factors I and II in healthy man. Estimations of half-lives and production rates. Acta Endocrinol (Copenh) 121:753-758, 1989
38. Neuenschwander S, Schwartz A, Wood TL, et al: Involution of the lactating mammary gland is inhibited by the IGF system in a transgenic mouse model. J Clin Invest 97:2225-2232, 1996
39. Werner H, Shen-Orr Z, Stannard B, et al: Experimental diabetes increases insulin-like growth factor I and II receptor concentration and gene expression in kidney. Diabetes 39:1490-1497, 1990
40. Flyvbjerg A, Kessler U, Dorka B, et al: Transient increase in renal insulin-like growth factor binding proteins during initial kidney hypertrophy in experimental diabetes in rats. Diabetologia 35:589-593, 1992
41. Ashton N, Ward B, Serpell G: Effect of oxygen on developing retinal vessels with particular reference to the problem of retrolental fibroplasia. Br J Ophthalmol 38:397-431, 1954
42. Chan-Ling T, Tour S, Hollander H, et al: Vascular changes and their mechanisms in the feline model of retinopathy of prematurity. Invest Ophthalmol Vis Sci 33:2128-2147, 1992
43. Penn JS, Henry MM, Tolman BL: Exposure to alternating hypoxia and hyperoxia causes severe proliferative retinopathy in the newborn rat. Pediatr Res 36:724-731, 1994
44. Varvarigou A, Vagenakis AG, Makri M, et al: Prolactin and growth hormone in perinatal asphyxia. Biol Neonate 69:76-83, 1996
45. Christensen H, Flyvbjerg A: Dose-dependent stimulatory effect of human growth hormone on the strength and collagen deposition of colonie anastomoses in the rat. Acta Endocrinol (Copenh) 126:438-443, 1992